JPH07228511A - Hair growing agent - Google Patents
Hair growing agentInfo
- Publication number
- JPH07228511A JPH07228511A JP6040442A JP4044294A JPH07228511A JP H07228511 A JPH07228511 A JP H07228511A JP 6040442 A JP6040442 A JP 6040442A JP 4044294 A JP4044294 A JP 4044294A JP H07228511 A JPH07228511 A JP H07228511A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- hair growing
- extract
- growing agent
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 52
- 239000000284 extract Substances 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 41
- 239000003795 chemical substances by application Substances 0.000 abstract description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 21
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract description 9
- 239000003814 drug Substances 0.000 abstract description 9
- 229940079593 drug Drugs 0.000 abstract description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 6
- -1 methanol or ethanol Chemical compound 0.000 abstract description 6
- 230000009471 action Effects 0.000 abstract description 5
- 150000005846 sugar alcohols Polymers 0.000 abstract description 5
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 238000005507 spraying Methods 0.000 abstract description 2
- 241000723353 Chrysanthemum Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 241000003690 Xanthium spinosum Species 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 230000003450 growing effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 17
- 239000004359 castor oil Substances 0.000 description 10
- 235000019438 castor oil Nutrition 0.000 description 10
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 10
- 230000003779 hair growth Effects 0.000 description 10
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 9
- 201000004384 Alopecia Diseases 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 230000003676 hair loss Effects 0.000 description 5
- 208000024963 hair loss Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000419 plant extract Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- 239000000469 ethanolic extract Substances 0.000 description 4
- 230000003658 preventing hair loss Effects 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 150000002500 ions Chemical group 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 239000000401 methanolic extract Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000000284 resting effect Effects 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical class CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 2
- 229950004580 benzyl nicotinate Drugs 0.000 description 2
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000003659 hair regrowth Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- UTTVXKGNTWZECK-UHFFFAOYSA-N n,n-dimethyloctadecan-1-amine oxide Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)[O-] UTTVXKGNTWZECK-UHFFFAOYSA-N 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 235000004400 serine Nutrition 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 230000004215 skin function Effects 0.000 description 2
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 2
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 2
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 2
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- WBIQQQGBSDOWNP-UHFFFAOYSA-N 2-dodecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O WBIQQQGBSDOWNP-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 description 1
- 241000569510 Spino Species 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Natural products NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 241001506766 Xanthium Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 description 1
- 229950003631 carpronium chloride Drugs 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- CAJZQACCKJCXLR-UHFFFAOYSA-N dodecyl 3-aminopropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCN CAJZQACCKJCXLR-UHFFFAOYSA-N 0.000 description 1
- 229940060296 dodecylbenzenesulfonic acid Drugs 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 230000031774 hair cycle Effects 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000003660 hair regeneration Effects 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は優れた脱毛防止、発毛効
果等の養毛作用を持つ養毛料に関する。本発明は、特に
医薬品、医薬部外品、或は化粧品分野において利用され
る。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a hair nourishing agent having excellent hair loss-preventing and hair-growing effects. The present invention is particularly used in the fields of medicines, quasi drugs, and cosmetics.
【0002】[0002]
【従来の技術】従来より、禿や脱毛の原因としては、毛
根、皮脂腺等の器官における男性ホルモンの活性化、毛
包への血流量の低下、皮脂の分泌過剰、過酸化物の生成
等による頭皮の異常等が考えられている。このため従来
の養毛料には、前記の原因を取り除いたり、または、軽
減する作用を持つ化合物が一般に配合されている。例え
ば、ビタミンB、ビタミンE等のビタミン類、セリン、
メチオニン等のアミノ酸類、センブリエキス、アセチル
コリン誘導体などの血管拡張剤、紫根エキス、ヒノキチ
オール等の抗炎症剤、エストラジオールなどの女性ホル
モン剤、セファランチンなどの皮膚機能亢進剤などが配
合され、脱毛症の予防および治療に用いられている。2. Description of the Related Art Conventionally, the causes of baldness and hair loss are activation of male hormones in organs such as hair roots and sebaceous glands, decrease in blood flow to hair follicles, excessive secretion of sebum, and generation of peroxides. Abnormalities of the scalp are considered. For this reason, conventional hair nourishing agents are generally blended with compounds having the action of removing or reducing the above causes. For example, vitamins such as vitamin B and vitamin E, serine,
Prevents alopecia by blending amino acids such as methionine, vasodilators such as assembly extract and acetylcholine derivatives, purple root extract, anti-inflammatory agents such as hinokitiol, female hormone agents such as estradiol, and skin function enhancers such as cepharanthin. And used in therapy.
【0003】[0003]
【発明が解決しようとする課題】しかしながら、前記の
ように種々の試みがなされているにもかかわらず、従来
の養毛剤ではその脱毛防止、発毛効果等の養毛作用は必
ずしも充分なものではなかった。これはおそらく、脱毛
の原因がさまざまであり、また発毛の機構も非常に複雑
であるためと考えられている。However, in spite of various attempts as described above, conventional hair nourishing agents do not always have sufficient hair nourishing effects such as hair loss prevention and hair growth effects. It was This is probably because there are various causes of hair loss and the mechanism of hair growth is very complicated.
【0004】本発明者は、上記のように養毛作用が不充
分であることに鑑み、脱毛に対して有効であり、優れた
脱毛防止、発毛効果の養毛作用を持つ物質を探索した結
果、アルコキスカの抽出物が強力な脱毛防止、発毛、育
毛作用を持つことを見出し、本発明を完成するに至っ
た。In view of the insufficient hair-feeding effect as described above, the present inventor searched for a substance which is effective for hair loss and has excellent hair-preventing and hair-growing effects. As a result, they have found that the extract of Alcoquisca has strong hair loss prevention, hair growth and hair growth effects, and completed the present invention.
【0005】[0005]
【課題を解決するための手段】すなわち、本発明は、ア
ルキコスカの抽出物を配合することを特徴とする養毛料
である。That is, the present invention is a hair nourishing agent characterized by containing an extract of Alkychosca.
【0006】以下、本発明の構成について詳述する。本
発明で用いられる植物抽出物の植物としては、ペルー生
薬であるキク科のアルキコスカ(地方名:Allco−
quisca、学名:Xanthium spinos
um L.)の全草の乾燥物が用いられる。The structure of the present invention will be described in detail below. The plant of the plant extract used in the present invention is a Peruvian crude drug Alchycocca (regional name: Allco-).
Quisca, Scientific name: Xanthium spinos
um L. ) Whole grass dry matter is used.
【0007】本発明で用いられる植物抽出物の抽出方法
としては植物を溶媒、例えば、熱水やメタノール、エタ
ノール等の低級アルコールあるいは含水低級アルコール
あるいはプロピレングリコール、1−3ブチレングリコ
ール等の多価アルコールあるいは含水多価アルコール等
の含水アルコール等で抽出して得られる。The method for extracting the plant extract used in the present invention is to use plants as a solvent, for example, hot water, lower alcohols such as methanol and ethanol, hydrous lower alcohols, or polyhydric alcohols such as propylene glycol and 1-3 butylene glycol. Alternatively, it can be obtained by extraction with hydrous alcohol such as hydrous polyhydric alcohol.
【0008】本発明で用いられる植物抽出物の配合量
は、養毛料全量中、乾燥物として0.005〜20重量
%、好ましくは0.01〜5重量%である。0.005
重量%未満であると、本発明でいう効果が十分に発揮さ
れず、20重量%を超えると製剤上好ましくない。The amount of the plant extract used in the present invention is 0.005 to 20% by weight, preferably 0.01 to 5% by weight, as a dried product, based on the total amount of the hair nourishing agent. 0.005
If it is less than 20% by weight, the effect of the present invention is not sufficiently exhibited, and if it exceeds 20% by weight, it is not preferable in terms of formulation.
【0009】本発明に係る養毛料には上記成分のほか、
化粧品、医薬部外品、医薬品等に一般に用いられる各種
成分、例えば、油分、例えば高級脂肪酸、固形パラフィ
ン、流動パラフィン、シリコーン油、スクワラン等;保
湿剤、例えばヒアルロン酸、プロピレングリコール、マ
ルチトール、アテロコラーゲン、乳酸ナトリウム等;増
粘剤、マルメロ粘質物、カルボキシビニールポリマー、
キサンタンガム等;モノオレイン酸グリセリル等の油
分、ニコチン酸アミド、ニコチン酸ベンジル、ビタミン
Eアセテート、センブリ抽出物、塩化カルプロニウム、
センブリエキス、アセチルコリン誘導体等の血管拡張
剤、セリン、メチオニン等のアミノ酸類、ビタミンB6
、ビタミンE及びその誘導体、ビオチン等のビタミン
類、パントテン酸及びその誘導体グリチルレチン酸及び
その誘導体、ニコチン酸ベンジルなどのニコチン酸エス
テル類、セファランチン等の皮膚機能亢進剤、エストラ
ジオール等の女性ホルモン剤等を同時に配合してもよ
い。さらに、通常、養毛料に用いられる添加剤、例え
ば、ヒノキチオール、ヘキサクロロフェン、ベンザルコ
ニウムクロリド、セチルピリジニウムクロリド、ウンデ
シレン酸、トリクロロカルバニリドおよびビチオノール
等の抗菌剤、メントール等の清涼剤、サリチル酸、亜鉛
およびその誘導体、乳酸およびそのアルキルエステルな
どの薬剤、クエン酸等の有機酸類、アルギニン等のアミ
ノ酸類、オリーブ油、スクワラン、流動パラフィン、イ
ソプロピルミリステート、高級脂肪酸、高級アルコール
等の油分、グリセリン、プロピレングリコール等の多価
アルコール、香料、酸化防止剤、紫外線吸収剤、色素、
エタノール、水、保湿剤、増粘剤等が本発明の効果を損
なわない範囲で適宜配合することができる。In addition to the above-mentioned components, the hair nourishing agent according to the present invention,
Various components commonly used in cosmetics, quasi drugs, pharmaceuticals, etc., such as oil, higher fatty acids, solid paraffin, liquid paraffin, silicone oil, squalane, etc .; moisturizers such as hyaluronic acid, propylene glycol, maltitol, atelocollagen , Sodium lactate, etc .; thickeners, quince mucilages, carboxyvinyl polymers,
Xanthan gum, etc .; oil such as glyceryl monooleate, nicotinamide, benzyl nicotinate, vitamin E acetate, cembly extract, carpronium chloride,
Assembly extract, vasodilators such as acetylcholine derivatives, amino acids such as serine and methionine, vitamin B6
, Vitamin E and its derivatives, vitamins such as biotin, pantothenic acid and its derivatives glycyrrhetinic acid and its derivatives, nicotinic acid esters such as benzyl nicotinate, skin function enhancers such as cepharanthin, and female hormone agents such as estradiol. You may mix simultaneously. Furthermore, additives usually used for hair nourishing agents, for example, hinokitiol, hexachlorophene, benzalkonium chloride, cetylpyridinium chloride, undecylenic acid, trichlorocarbanilide and antibacterial agents such as biothionol, a refreshing agent such as menthol, salicylic acid, Drugs such as zinc and its derivatives, lactic acid and its alkyl esters, organic acids such as citric acid, amino acids such as arginine, olive oil, squalane, liquid paraffin, isopropyl myristate, oils such as higher fatty acids and higher alcohols, glycerin, propylene Polyhydric alcohol such as glycol, fragrance, antioxidant, ultraviolet absorber, dye,
Ethanol, water, a moisturizer, a thickener, etc. can be appropriately added within a range that does not impair the effects of the present invention.
【0010】本発明の養毛料の性状は、液状、乳液、軟
膏など外皮に適用できる性状のものであればいずれでも
よい。本発明の養毛料は皮膚に直接に塗布または散布す
る経皮投与による投与方法をとる。また、本発明の養毛
料の投与量は、年齢、個人差、病状等により変化するの
で明確には確定できないが、一般に人に投与する場合の
投与量は体重1kgおよび1日当り0.01〜100 mg、好
ましくは0.1 〜10mgであり、 この量を1日1回または
2〜4回に分けて投与することができる。The hair nourishing agent of the present invention may have any properties as long as it can be applied to the outer skin such as liquid, emulsion and ointment. The hair nourishing agent of the present invention is administered by percutaneous administration by directly applying or spraying on the skin. Further, the dose of the hair nourishing agent of the present invention cannot be clearly determined because it varies depending on age, individual differences, medical conditions, etc., but generally when administered to humans, the dose is 1 kg of body weight and 0.01 to 100 mg per day, It is preferably 0.1 to 10 mg, and this amount can be administered once a day or divided into 2 to 4 times.
【0011】[0011]
【実施例】次に実施例をあげて本発明の養毛料の製法お
よび養毛作用をさらに具体的に説明する。本発明はこれ
により限定されるものではない。配合量は重量%であ
る。EXAMPLES Next, the production method and the hair-retaining action of the hair nourishing agent of the present invention will be described in more detail with reference to examples. The present invention is not limited to this. The blending amount is% by weight.
【0012】実施例1 70%エタノール90%にアルキコスカのメタノールエ
キス乾燥物1.0%、イオン交換水(残余)および硬化
ヒマシ油エチレンオキシド(40 モル) 付加物1.0%を
添加し、 攪拌溶解させ、 次いでイオン交換水を添加、混
合して実施例1の液状の養毛料を得た。Example 1 To 90% of 70% ethanol, 1.0% of a dry product of methanol extract of Alkychosca, ion-exchanged water (residual) and 1.0% of hydrogenated castor oil ethylene oxide (40 mol) adduct were added, and dissolved by stirring. Then, ion-exchanged water was added and mixed to obtain a liquid hair nourishing agent of Example 1.
【0013】実施例2 70%エタノール90%にアルキコスカの70%エタノ
ールエキス乾燥物0.1%、イオン交換水(残余)、オ
レイン酸ナトリウム0.01%、ドデシルベンゼンスル
ホン酸0.49%および硬化ヒマシ油エチレンオキシド
(40 モル) 付加物0.5%を添加し、 攪拌溶解させ、 次
いでイオン交換水を添加、混合して実施例2の液状の養
毛料を得た。Example 2 90% 70% ethanol, 0.1% dry product of 70% ethanol extract of Archicosca, ion-exchanged water (residual), sodium oleate 0.01%, dodecylbenzenesulfonic acid 0.49% and curing Castor oil ethylene oxide
(40 mol) 0.5% of an adduct was added and dissolved by stirring, and then ion-exchanged water was added and mixed to obtain a liquid hair nourishing agent of Example 2.
【0014】実施例3 70%エタノール90%にアルキコスカの酢酸エチルエ
ステルエキス乾燥物0.05%、イオン交換水(残
余)、ラウリルジメチルアミンオキシド0.1%および
硬化ヒマシ油エチレンオキシド(60 モル) 付加物0.9
%を添加し、 攪拌溶解させ、 次いでイオン交換水を添
加、混合して実施例3の液状の養毛料を得た。Example 3 To 90% of 70% ethanol, 0.05% of dry product of ethyl ester extract of Alkychosca, ion-exchanged water (residual), 0.1% of lauryldimethylamine oxide and hydrogenated castor oil ethylene oxide (60 mol) were added. Thing 0.9
%, And dissolved by stirring, and then ion-exchanged water was added and mixed to obtain a liquid hair nourishing agent of Example 3.
【0015】実施例4 70%エタノール90%にアルキコスカのアセトンエキ
ス乾燥物1.0%、イオン交換水(残余)、セスキオレ
イン酸ソルビタン0.4%および硬化ヒマシ油エチレン
オキシド(40 モル) 付加物0.6%を添加し、 攪拌溶解
させ、 次いでイオン交換水を添加、混合して実施例4の
液状の養毛料を得た。Example 4 90% 70% ethanol, 1.0% dry product of acetone extract of Alkychosca, ion-exchanged water (residual), 0.4% sorbitan sesquioleate and hydrogenated castor oil ethylene oxide (40 mol) adduct 0 6% was added and dissolved by stirring, and then ion-exchanged water was added and mixed to obtain a liquid hair nourishing agent of Example 4.
【0016】実施例5 70%エタノール90%にアルキコスカの40%エタノ
ールエキス乾燥物0.3%、イオン交換水(残余)、ラ
ウロイルタウリン0.1%、塩化セチルピリジニウム
0.01%および硬化ヒマシ油エチレンオキシド(40 モ
ル) 付加物0.89%を添加し、 攪拌溶解させ、 次いで
イオン交換水を添加、混合して実施例5の液状の養毛料
を得た。EXAMPLE 5 90% 70% ethanol, 0.3% dried 40% ethanol extract of Alkychosca, ion-exchanged water (residual), 0.1% lauroyl taurine, 0.01% cetylpyridinium chloride and hydrogenated castor oil 0.89% of ethylene oxide (40 mol) adduct was added, dissolved by stirring, and then ion-exchanged water was added and mixed to obtain a liquid hair nourishing agent of Example 5.
【0017】発毛試験 実施例1〜5および比較例1の発毛試験を毛周期の休止
期にあるC3H/HeNCrJマウスを用い、小川らの
方法(ノーマル アンド アブノーマル エピダーマル
ディファレンシェーション[Normal and Abnormal Epi
dermal Differentiation] 、 M.Seiji およびI.A.Bernst
ein 編集、 第159 〜170 ページ、1982年、東大出版)に
より行なった。すなわち、マウスを1群10匹とし、実
施例1〜5および比較例1(70%エタノール)の6群
に分け、バリカンおよびシェーバーでマウスの背部を剃
毛し、それぞれのサンプルを1日1回、0.1mlずつ
塗布した。実施例1〜5および比較例1のそれぞれの試
料による毛の再生面積(25日後)の結果は次の通りで
あった。Hair Growth Test The hair growth tests of Examples 1 to 5 and Comparative Example 1 were carried out using C3H / HeNCrJ mice in the resting phase of the hair cycle, by the method of Ogawa et al. (Normal and Abnormal Epidermal Difference [Normal and Abnormal Epi
dermal Differentiation], M. Seiji and IABernst
edited by ein, pp. 159-170, 1982, University of Tokyo). That is, one group of 10 mice was divided into 6 groups of Examples 1 to 5 and Comparative Example 1 (70% ethanol), the back of each mouse was shaved with a clipper and a shaver, and each sample was once a day. , 0.1 ml each. The results of the hair regrowth area (after 25 days) of the samples of Examples 1 to 5 and Comparative Example 1 were as follows.
【0018】 試料 毛再生面積 比較例1 5.0% 実施例1 85.5% 実施例2 80.0% 実施例3 90.0% 実施例4 91.5% 実施例5 84.0% 上記の結果から明らかなように各実施例(本発明)にお
いてその毛の再生に対する有意な効果が認められた。Sample Hair Regeneration Area Comparative Example 1 5.0% Example 1 85.5% Example 2 80.0% Example 3 90.0% Example 4 91.5% Example 5 84.0% As is clear from the above results, a significant effect on hair regrowth was observed in each Example (the present invention).
【0019】養毛作用試験 次に本発明の養毛料の脱毛防止、発毛効果等の養毛作用
を調べるために、人に対して、トリコグラム試験を実施
した。実施例1、比較例1について行なった。トリコグ
ラム試験について以下に説明する。養毛料の使用前と使
用後の抜去毛髪の毛根を顕微鏡下で観察し、毛根の形態
から休止期毛根数を計数し、その割合の増減によって養
毛料の養毛作用を比較した。休止期毛根とは成長の止ま
った毛の毛根であり、脱毛を訴える人は正常な人よりも
この休止期毛根の割合が多いことが認められている。実
施例1および比較例1の各養毛料をそれぞれ男性被験者
10名の頭皮に1日2回、1回2mlずつ6カ月間連続し
て塗布し、塗布直前および6カ月間塗布終了直後に被験
者1名につき100 本ずつ毛髪を抜去し、それぞれの毛根
を調べ、実使用テストを行った。結果は表1に示す。Hair nourishing test Next, in order to investigate the hair nourishing effects such as hair loss prevention and hair growth effect of the hair nourishing agent of the present invention, a trichogram test was carried out on humans. Example 1 and Comparative Example 1 were performed. The trichogram test is described below. The hair roots of the removed hair before and after the use of the hair nourishment were observed under a microscope, and the number of resting hair roots was counted from the form of the hair root, and the hair nourishing action of the hair nourishing agent was compared by increasing or decreasing the ratio. Resting hair roots are hair roots that have stopped growing, and it has been recognized that people who complain of hair loss have a higher proportion of resting hair roots than normal people. Each of the hair nourishing preparations of Example 1 and Comparative Example 1 was applied to a male subject.
It was applied to the scalp of 10 people twice a day, 2 ml each, continuously for 6 months, and 100 hairs were removed from each subject immediately before and 6 months after the application, and each hair root was examined. , The actual use test was done. The results are shown in Table 1.
【0020】[0020]
【表1】 [Table 1]
【0021】表1の結果から明らかなように実施例にお
いてその養毛効果が優れていることがわかる。As is clear from the results of Table 1, the hair-growth effect is excellent in Examples.
【0022】実施例6 (A 相) アルキコスカのエタノールエキス乾燥物 1.0 ホ゜リオキシエチレン(60モル) 付加硬化ヒマシ油 2.0 グリセリン 10.0 ジプロピレングリコール 10.0 1,3 −ブチレングリコール 5.0 ポリエチレングリコール1500 5.0 (B 相) セチルイソオクタネート 10.0 スクワラン 5.0 ワセリン 2.0 プロピルパラベン 2.0 (C 相) カルボキシビニルポリマー1%水溶液 30.0 ヘキサメタリン酸ソーダ 0.03 イオン交換水 8.35 (D 相) イオン交換水 4.5 (E 相) カセイカリ 0.12 イオン交換水 5.0 (製造法)A相、B相をそれぞれ60°Cで加熱溶解
し、混合してホモミキサー処理しゲルを作る。これにD
相を徐々に添加しホモミキサーで分散する。次にこれに
溶解したC相を加え、最後に溶解したE相を添加しホモ
ミキサーで乳化してO/W乳液型の養毛料を得た。この
養毛料を実施例1と同様に人に対して、実使用テストを
行ったところ、その養毛作用が優れていることが確認さ
れた。Example 6 (Phase A) Dried Alkikosca Ethanol Extract 1.0 Polyoxyethylene (60 mol) Addition-hardened castor oil 2.0 Glycerin 10.0 Dipropylene glycol 10.0 1,3-butylene glycol 5.0 Polyethylene glycol 1500 5.0 (Phase B) Cetyl isooctanoate 10.0 Squalane 5.0 Vaseline 2.0 Propylparaben 2.0 (C phase) Carboxyvinyl polymer 1% aqueous solution 30.0 Sodium hexametaphosphate 0.03 Ion exchanged water 8.35 (D phase) Ion exchanged water 4.5 (E phase) Causticari 0.12 Ion exchanged water 5.0 ( Manufacturing method) Phases A and B are each melted by heating at 60 ° C, mixed and treated with a homomixer to form a gel. D to this
Add the phases slowly and disperse with a homomixer. Next, dissolved C phase was added thereto, and finally dissolved E phase was added and emulsified with a homomixer to obtain an O / W emulsion type hair nourishing agent. When this hair nourishing agent was subjected to a practical use test to humans as in Example 1, it was confirmed that the hair nourishing action was excellent.
【0023】実施例7 (A 相) 流動パラフィン 5.0 セトステアリルアルコール 5.5 グリセリルモノステアレート 3.0 EO(20モル)-2- オクチルドデシルエーテル 3.0 プロピルパラベン 0.3 香料 0.1 (B 相) アルキコスカのメタノールエキス乾燥物 5.0 グリセリン 8.0 ジプロピレングリコール 20.0 ポリエチレングリコール4000 5.0 ドデシル硫酸ナトリウム 0.1 ヘキサメタリン酸ソーダ 0.005 イオン交換水 45.095 (製造法)A相、B相をそれぞれ加熱溶解して混合し、
ホモミキサーで乳化してクリーム状養毛料を得た。この
養毛料を実施例1と同様に人に対して、実使用テストを
行ったところ、その養毛効果が優れていることが確認さ
れた。Example 7 (Phase A) Liquid paraffin 5.0 Cetostearyl alcohol 5.5 Glyceryl monostearate 3.0 EO (20 mol) -2-Octyldodecyl ether 3.0 Propylparaben 0.3 Perfume 0.1 (Phase B) Alkycoska methanol extract dry matter 5.0 Glycerin 8.0 Dipropylene glycol 20.0 Polyethylene glycol 4000 5.0 Sodium dodecyl sulfate 0.1 Sodium hexametaphosphate 0.005 Ion-exchanged water 45.095 (Production method) Phase A and phase B are dissolved by heating and mixed,
The mixture was emulsified with a homomixer to obtain a creamy hair nourishing agent. When this hair nourishing agent was subjected to a practical use test on humans as in Example 1, it was confirmed that the hair nourishing effect was excellent.
【0024】実施例8 アルキコスカのエタノールエキス乾燥物 0.5 ステアリルジメチルアミンオキシド 0.5 硬化ヒマシ油エチレンオキシド(40モル)付加物 1.0 95%エタノール 54.0 イオン交換水 残部 (製造法)95%エタノールにイオン交換水を加え、こ
れに硬化ヒマシ油エチレンオキシド(40モル)付加物
およびステアリルジメチルアミンオキシドを加えた後各
植物抽出物を加え、撹拌溶解する。この養毛料を実施例
1と同様に人に対して、実使用テストを行ったところ、
その養毛効果が優れていることが確認された。Example 8 Alkychosca ethanol extract dried product 0.5 Stearyl dimethylamine oxide 0.5 Hardened castor oil Ethylene oxide (40 mol) adduct 1.0 95% ethanol 54.0 Ion-exchanged water balance (manufacturing method) Ion-exchanged water was added to 95% ethanol. Then, hydrogenated castor oil ethylene oxide (40 mol) adduct and stearyl dimethylamine oxide were added thereto, and then each plant extract was added and dissolved by stirring. When this hair nourishment was subjected to an actual use test to a person in the same manner as in Example 1,
It was confirmed that the hair-growth effect was excellent.
【0025】実施例9 N−ヤシラウリル−β−アミノプロピオン酸ソーダ 0.2 アルキコスカのメタノールエキス乾燥物 1.0 ドデシルベンゼンスルホン酸ナトリウム 0.5 硬化ヒマシ油エチレンオキシド(40モル)付加物 1.0 95%エタノール 54.0 イオン交換水 残部 (製造法)95%エタノールにイオン交換水を加え、こ
れに硬化ヒマシ油エチレンオキシド(40モル)付加
物、ドデシルベンゼンスルホン酸ナトリウムおよびN−
ヤシラウリル−β−アミノプロピオン酸ソーダを加えた
後各植物抽出物を加え、撹拌溶解する。この養毛料を実
施例1と同様に人に対して、実使用テストを行ったとこ
ろ、その養毛効果が優れていることが確認された。Example 9 N-Paylauryl-β-aminopropionate sodium 0.2 Alkychosca methanol extract dry product 1.0 Sodium dodecylbenzenesulfonate 0.5 Hydrogenated castor oil ethylene oxide (40 mol) adduct 1.0 95% ethanol 54.0 Ion-exchanged water balance ( Production method) Ion-exchanged water was added to 95% ethanol, and hydrogenated castor oil ethylene oxide (40 mol) adduct, sodium dodecylbenzenesulfonate and N-
After adding coconut lauryl-β-aminopropionate soda, each plant extract is added and dissolved by stirring. When this hair nourishing agent was subjected to a practical use test on humans as in Example 1, it was confirmed that the hair nourishing effect was excellent.
【0026】[0026]
【発明の効果】本発明の養毛料は、脱毛防止効果、発毛
効果等に優れるものである。The hair nourishing agent of the present invention is excellent in hair loss prevention effect, hair growth effect and the like.
Claims (1)
徴とする養毛料。1. A hair nourishing agent containing an extract of Alcoquisca.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6040442A JPH07228511A (en) | 1994-02-15 | 1994-02-15 | Hair growing agent |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6040442A JPH07228511A (en) | 1994-02-15 | 1994-02-15 | Hair growing agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH07228511A true JPH07228511A (en) | 1995-08-29 |
Family
ID=12580768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP6040442A Withdrawn JPH07228511A (en) | 1994-02-15 | 1994-02-15 | Hair growing agent |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH07228511A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100769479B1 (en) * | 2006-03-28 | 2007-10-23 | 정연철 | Hair Regrowth Shampoo Composition |
-
1994
- 1994-02-15 JP JP6040442A patent/JPH07228511A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100769479B1 (en) * | 2006-03-28 | 2007-10-23 | 정연철 | Hair Regrowth Shampoo Composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2444282C (en) | Preparation for hair and/or scalp | |
| JP3220761B2 (en) | Hair restoration | |
| EP0998907B1 (en) | Hair tonic composition comprising adenosine | |
| JPH11302133A (en) | Cosmetic for scalp and hair | |
| JP2001139436A (en) | Hair tonic and grower | |
| JP3542700B2 (en) | Head composition | |
| JPH11302131A (en) | Cosmetic for scalp and hair | |
| JPH0640858A (en) | Hair tonic | |
| JPH07206647A (en) | Hair tonic | |
| JPH07228511A (en) | Hair growing agent | |
| JP2566792B2 (en) | Hair growth and hair growth promoter | |
| JPH07277930A (en) | Hair growth material | |
| JP4577596B2 (en) | Hair restorer or hair growth agent and method of use thereof | |
| JPH07228512A (en) | Hair growing agent | |
| JPH07149614A (en) | Hair tonic agent | |
| JPH08231352A (en) | Hair tonic | |
| JPH08231353A (en) | Hair tonic | |
| JP2814090B2 (en) | Hair restoration | |
| JP2787451B2 (en) | Hair restoration | |
| JPH08231351A (en) | Hair tonic | |
| JPH0352806A (en) | Hair-raising agent | |
| JPH11302128A (en) | Cosmetic for scalp and hair | |
| JP2998939B2 (en) | Hair restoration | |
| JPH11269044A (en) | Hair tonic | |
| JPH09227342A (en) | Hair-tonic and hair-growing agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20010508 |